X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Dr. Reddys with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs GSK PHARMA - Comparison Results

DR. REDDYS LAB    Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB GSK PHARMA DR. REDDYS LAB/
GSK PHARMA
 
P/E (TTM) x 22.2 49.4 45.0% View Chart
P/BV x 3.4 10.2 33.2% View Chart
Dividend Yield % 0.8 2.8 27.6%  

Financials

 DR. REDDYS LAB   GSK PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-18
GSK PHARMA
Mar-18
DR. REDDYS LAB/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs2,7882,760 101.0%   
Low Rs1,9022,040 93.2%   
Sales per share (Unadj.) Rs860.8339.0 253.9%  
Earnings per share (Unadj.) Rs57.141.4 137.8%  
Cash flow per share (Unadj.) Rs122.045.9 265.8%  
Dividends per share (Unadj.) Rs20.0035.00 57.1%  
Dividend yield (eoy) %0.91.5 58.5%  
Book value per share (Unadj.) Rs757.7242.9 312.0%  
Shares outstanding (eoy) m165.9184.70 195.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.77.1 38.5%   
Avg P/E ratio x41.157.9 70.9%  
P/CF ratio (eoy) x19.252.3 36.8%  
Price / Book Value ratio x3.19.9 31.3%  
Dividend payout %35.084.5 41.5%   
Avg Mkt Cap Rs m389,034203,280 191.4%   
No. of employees `00023.5NA-   
Total wages/salary Rs m32,1495,234 614.2%   
Avg. sales/employee Rs Th6,070.8NM-  
Avg. wages/employee Rs Th1,366.6NM-  
Avg. net profit/employee Rs Th402.5NM-  
INCOME DATA
Net Sales Rs m142,81028,715 497.3%  
Other income Rs m1,552545 284.5%   
Total revenues Rs m144,36229,260 493.4%   
Gross profit Rs m23,5125,059 464.8%  
Depreciation Rs m10,772380 2,834.7%   
Interest Rs m7882 39,400.0%   
Profit before tax Rs m13,5045,222 258.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m3440-   
Extraordinary Inc (Exp) Rs m0178 0.0%   
Tax Rs m4,3801,892 231.5%   
Profit after tax Rs m9,4683,508 269.9%  
Gross profit margin %16.517.6 93.5%  
Effective tax rate %32.436.2 89.5%   
Net profit margin %6.612.2 54.3%  
BALANCE SHEET DATA
Current assets Rs m104,98421,815 481.3%   
Current liabilities Rs m68,93815,999 430.9%   
Net working cap to sales %25.220.3 124.6%  
Current ratio x1.51.4 111.7%  
Inventory Days Days7464 116.9%  
Debtors Days Days10419 554.3%  
Net fixed assets Rs m104,38512,475 836.8%   
Share capital Rs m830847 98.0%   
"Free" reserves Rs m124,88619,726 633.1%   
Net worth Rs m125,71620,573 611.1%   
Long term debt Rs m25,0896 418,150.0%   
Total assets Rs m225,44339,475 571.1%  
Interest coverage x18.12,612.0 0.7%   
Debt to equity ratio x0.20 68,429.8%  
Sales to assets ratio x0.60.7 87.1%   
Return on assets %4.58.9 51.2%  
Return on equity %7.517.1 44.2%  
Return on capital %9.726.2 37.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m72,623564 12,876.4%   
Fx outflow Rs m18,9167,429 254.6%   
Net fx Rs m53,707-6,865 -782.3%   
CASH FLOW
From Operations Rs m18,0304,728 381.3%  
From Investments Rs m-14,883-1,042 1,428.4%  
From Financial Activity Rs m-4,440-3,066 144.8%  
Net Cashflow Rs m-1,236620 -199.5%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 5.4 10.2 52.9%  
FIIs % 35.3 23.8 148.3%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 15.4 99.4%  
Shareholders   75,885 102,036 74.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   PANACEA BIOTECH  DISHMAN PHARMA  J.B.CHEMICALS  NATCO PHARMA  DIVIS LABORATORIES  

Compare DR. REDDYS LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Strong Note; Sensex Ends 489 Points Higher(Closing)

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 16.6% YoY). Sales on the other hand came in at Rs 8 bn (up 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0% (Quarterly Result Update)

Feb 5, 2019 | Updated on Feb 5, 2019

For the quarter ended December 2018, GSK PHARMA has posted a net profit of Rs 1 bn (up 26.0% YoY). Sales on the other hand came in at Rs 8 bn (up 17.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jun 20, 2019 03:35 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - WYETH LTD COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS